These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 1004490)

  • 1. Further characterization of specific drug binding sites on human serum albumin.
    Sudlow G; Birkett DJ; Wade DN
    Mol Pharmacol; 1976 Nov; 12(6):1052-61. PubMed ID: 1004490
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of fatty acids on the interaction of 1-anilino-8-naphthalenesulfonate with human plasma albumin.
    Santos EC; Spector AA
    Mol Pharmacol; 1974 May; 10(3):519-28. PubMed ID: 4851749
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of fatty acids on two specific drug binding sites on human serum albumin.
    Birkett DJ; Myers SP; Sudlow G
    Mol Pharmacol; 1977 Nov; 13(6):987-92. PubMed ID: 593269
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
    Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
    J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The characterization of two specific drug binding sites on human serum albumin.
    Sudlow G; Birkett DJ; Wade DN
    Mol Pharmacol; 1975 Nov; 11(6):824-32. PubMed ID: 1207674
    [No Abstract]   [Full Text] [Related]  

  • 6. Measurements of drug-protein binding by using immobilized human serum albumin liquid chromatography-mass spectrometry.
    Cheng Y; Ho E; Subramanyam B; Tseng JL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):67-73. PubMed ID: 15282095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrospray ionization mass spectrometry as a tool for determination of drug binding sites to human serum albumin by noncovalent interaction.
    Benkestock K; Edlund PO; Roeraade J
    Rapid Commun Mass Spectrom; 2005; 19(12):1637-43. PubMed ID: 15915474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interaction of prostaglandin E2 with human serum albumin].
    Buko VU; Zavodnik IB; Stepuro II
    Biokhimiia; 1987 Jun; 52(6):891-5. PubMed ID: 3478094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective binding of etodolac to human serum albumin.
    Muller N; Lapicque F; Monot C; Payan E; Dropsy R; Netter P
    Chirality; 1992; 4(4):240-6. PubMed ID: 1389961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective protein binding of ketoprofen: effect of albumin concentration and of the biological system.
    Dubois N; Lapicque F; Abiteboul M; Netter P
    Chirality; 1993; 5(3):126-34. PubMed ID: 8338722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.
    Olsen H; Andersen A; Nordbø A; Kongsgaard UE; Børmer OP
    BMC Clin Pharmacol; 2004 Mar; 4():4. PubMed ID: 15046641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining binding sites of drugs on human serum albumin using FIA-QCM.
    Zhang Q; Huang Y; Zhao R; Liu G; Chen Y
    Biosens Bioelectron; 2008 Sep; 24(1):48-54. PubMed ID: 18436441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of the drug-binding specificity of human serum albumin.
    Ghuman J; Zunszain PA; Petitpas I; Bhattacharya AA; Otagiri M; Curry S
    J Mol Biol; 2005 Oct; 353(1):38-52. PubMed ID: 16169013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectroscopic techniques in the study of protein binding: the use of 1-anilino-8-naphthalenesulphonate as a fluorescent probe for the study of the binding of iophenoxic and iopanoic acids to human serum albumin.
    Sudlow G; Birkett DJ; Wade DN
    Mol Pharmacol; 1973 Sep; 9(5):649-57. PubMed ID: 4788159
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug therapy. Binding of drugs to serum albumin (second of two parts).
    Koch-Weser J; Sellers EM
    N Engl J Med; 1976 Mar; 294(10):526-31. PubMed ID: 765821
    [No Abstract]   [Full Text] [Related]  

  • 16. Binding of adrenergic beta-receptor antagonists to human serum albumin.
    Appelgren C; Borg KO; Elofsson R; Johansson KA
    Acta Pharm Suec; 1974 Sep; 11(4):325-32. PubMed ID: 4153285
    [No Abstract]   [Full Text] [Related]  

  • 17. [The in vitro interaction between human albumin and cephazolin].
    Fernández GM; Lumbreras JM; Ordóñez D; Santiago D; Sanz F
    Arch Farmacol Toxicol; 1983 Apr; 9(1):29-38. PubMed ID: 6625673
    [No Abstract]   [Full Text] [Related]  

  • 18. Binding of 3-carbethoxipsoralen to human serum albumin and human serum: influence of free fatty acids.
    Font G; Mañes J; Martre H; Prognon P; Mahuzier G
    Rev Esp Fisiol; 1987 Sep; 43(3):317-21. PubMed ID: 3423390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method dependence of apparent stoichiometry in the binding of salicylate ion to human serum albumin: a comparison between equilibrium dialysis and fluorescence titration.
    Ozer I; Tacal O
    Anal Biochem; 2001 Jul; 294(1):1-6. PubMed ID: 11411999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism.
    Ascoli GA; Domenici E; Bertucci C
    Chirality; 2006 Sep; 18(9):667-79. PubMed ID: 16823814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.